8049 — Jilin Province Huinan Changlong Bio-pharmacy Share News
0.000.00%
- HK$1.48bn
- HK$426.16m
- CNY901.87m
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribs For Wealth Management Product From Bank Of China
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts QTRLY Profit Attributable RMB31.3 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Subscribed For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product Of Rmb40 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts FY Turnover RMB 645.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Announces Subscriptions Of Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Price For Global Offering HK$2.35 Per H Share
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product From ICBC In Amount Of Rmb40 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribed For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribed For Wealth Management Product From CCB
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Q1 Profit Attributable Of RMB15.3 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For China Construction Bank Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product For RMB20 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts FY Profit Attributable RMB161.2 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Updates On Subscription For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy-Co Subscribed For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Subscribed For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Subscribes For Wealth Management Product Of Rmb30 Mln